1. Isothermal Nucleic Acid Amplification Technologies Market
(2012-2017) (Molecular diagnostics, infectious disease testing,
blood screening, cancer research, rapid testing)
Report Details:
Published:October 2012
No. of Pages: 144
Price: Single User License – US$4650
The research analysis titled “Isothermal Nucleic Acid Amplification Technologies (INAAT)”
discloses the promising trends in Nucleic acid testing and their applications in molecular
diagnostics and laboratory research on a global scale. The World Health Organization (WHO)
proposes that, an ideal diagnostic test that is suitable for developing countries, should be
Affordable, Sensitive, Specific and User-friendly (simple to perform in a few steps with minimal
training), Robust and rapid (results available in minutes), Equipment free and Deliverable to the
end user (ASSURED). Nucleic acid amplification tests targeting pathogen markers have high
sensitivity and specificity, but generally fail to meet the ASSURED guidelines in terms of
affordability, rapidity, and being equipment free. However, INAAT has recently attracted the
scientific community due to their operation in single temperature and distinct features by meeting
the ASSURED guidelines. With fine-tunings in the amplification methodology, a variety of INAAT
types are discovered each being independent, driving the diagnostic platform towards Point-Of-
Care (POC) testing at low resource settings.
This research report provides in-depth details about technology evolution, and innovation trends
across the industry, technology investment potential and competitive market landscape. The
analyses ensuing out of this research service may provide, useful insights for end users, while
prioritizing the appropriate choice of modality for nucleic acid testing in research and diagnostics.
In brief, this research report provides:
•A detailed description of the global technology developments and evolving trends, in the INAAT
field with key prominence on product innovations by industries, and collaborative efforts by the
academic research institutions.
•A comprehensive picture of the different types of INAAT platforms available with an exhaustive
overview of their application prospective.
•An impact analysis of major drivers, restraints and challenges influencing the adoption and
growth of INAAT during the period from 2012 to 2017.
•Market size - Global market forecast for the next 5 years, including demand side analysis and
strategic recommendations for technology/product developers.

2. •Prioritized INNAT types through the Analytical Hierarchy Process (AHP) based on competitive
benchmarking, technology management strategies and technology roadmap.
•Competitive landscape based on the analysis of key patents and research publications that gives
an insight into prominent activities and global participants.
Main Driver:
•Global prevalence of infections and cancer: An effective diagnosis of diseases is the first step
towards personalized medicine. Over 1 billion people are afflicted owing to infectious diseases
and cancer especially in the tropical/developing countries where access to diagnostics labs are
limited.
Main Restraint:
•Conservative mindset for INAAT usage: Most of the end users perceive PCR to be more
reliable standard for detection. This is true for some of the developing and developed countries.
Owing to the lack of knowledge or awareness about the advances in the latest technological
developments in INAAT. This is perceived as a restraint for INAAT market
Main Challenge:
•Market penetration of INAAT: Penetrating new markets in China, India and Middle could be
competitive for INAAT based players due to high competition from players who are already
suppliers of PCR based products. However this could be a big advantage for PCR diagnostic
product manufacturers, since they have capability to adopt these new technologies.
Get your copy of this report @
http://www.reportsnreports.com/reports/202345-isothermal-nucleic-acid-amplification-technologies-market-2012-
2017-molecular-diagnostics-infectious-disease-testing-blood-screening-cancer-research-rapid-testing-.html
Major points covered in Table of Contents of this report include
TABLE OF CONTENTS
1 Introduction
1.1 Key Take-Aways
1.2 Report Scope
1.3 Research Methodology
1.4 Key Data Sources
2 Executive Summary
3 Isothermal Nucleic Acid Amplification Technologies (INAAT) – Technology Landscape
Analysis
3.1 Technology Overview
3.2 INAAT Vs Conventional Methods – Competitive Advantages
3.3 Technology Value Chain Analysis
3.4 Comparative Analysis Of INAAT Types
3.5 Applications
3.5.1 INAAT - Molecular Diagnostics
3.5.1.1. Infectious Disease Diagnostics
3.5.1.2. Blood Screening
3.5.2 INAAT - Research Applications

3. 3.5.2.1 Laboratory Research
3.5.2.2 Cancer Research
3.6 Product/Technology Innovations - Applications
4 Technology Investment Potential
4.1 Investment Climate Assessment
4.1.1 Public Funding Bodies
4.1.2 Philanthropic Bodies
4.1.3 Private Investors & Venture Capital Firms
4.1.4 Insights On Current And Future Tech-Investment Trends
4.1.5 Some Of The Funds And Investments On INAAT
4.2 Investor Network
4.2.1 Investment Opportunities
4.2.1.1 Evaluation Of Technologies Available For Licensing & Acquisition For Stakeholders
4.2.2.2 Analysis Of Potential Application Areas For Technology Investment Using OSE Grid
5 INAAT - Market Landscape Analysis
5.1 Market Segmentation
5.2 INAAT Market Share In Molecular Diagnostics (MDX)
5.3 Global Market Forecast
5.3.1 By Geography
5.3.2 By Applications
5.4 Market Dynamics
5.4.1 Drivers
5.4.2 Restraints
5.4.3 Challenges
5.4.4 Current And Emerging Opportunities
5.5 Demand Side Analysis
6 INAAT – Technology Adoption Potential And Development By Geography
6.1 Technology Adoption & Development – Key Findings
6.2 North America
6.3 Europe
6.4 ASIA
6.5 Rest Of The World
6.6 Regions With High Technology Adoption
7 Competitive Landscape
7.1 Mergers & Acquisitions (2007-2012)
7.2 Partnerships & Collaborations (2007-2012)
7.3 New Product Development Initiatives – 2012
7.3.1 List of NEW approved INAAT products – 2012
7.3.2 INAAT products – IN Pipeline
7.3.3 Research Innovations
8 Patent Analysis And Research Trend (Publications) 2007-2012
8.1 Patent Landscape Analysis (2007-2012)

4. 8.2 Research Landscape (2007-2012)
9 TECHNOLOGY ANALYSIS (USING AHP) AND ROAD MAPPING
10 Analyst Insights And Recommendations
10.1 Strategic Recommendations For Technology And Business Management
10.2 Key Invitations & Opportunities
11 Company Profiles
11.1 BECTON, DICKINSON AND COMPANY (BD)
11.2 BIOHELIX
11.3 BIOMERIEUX
11.4 EIKEN CHEMICAL CO., LTD.
11.5 HOLOGIC GEN-PROBE
11.6 LUCIGEN
11.7 MERIDIAN BIOSCIENCE INC
11.8 NEW ENGLAND BIOLABS
11.9 NOVARTIS DIAGNOSTICS
11.1 NUGEN
11.11 QIAGEN
11.12 TWISTDX
11.13 USTAR BIOTECHNOLOGIES (HANGZHOU) LTD.
12 Appendix
13 Glossary
Contact: sales@reportsandreports.com for more information.